BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (Q24610409)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received |
scientific article |
Statements
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received (English)
0 references
24 August 2010
0 references
103
0 references
5
0 references
668-75
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference